576 related articles for article (PubMed ID: 18359480)
1. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
Ramos AM; Aller P
Biochem Pharmacol; 2008 May; 75(10):1912-23. PubMed ID: 18359480
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of arsenic trioxide-induced apoptosis by 8-bromo-7-methoxychrysin in human leukemia cells involves depletion of intracellular reduced glutathione.
Xiao G; Tang X; Yao C; Wang C
Acta Biochim Biophys Sin (Shanghai); 2011 Sep; 43(9):712-21. PubMed ID: 21785114
[TBL] [Abstract][Full Text] [Related]
3. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P
J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
[TBL] [Abstract][Full Text] [Related]
4. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation.
Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P
Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis.
Ramos AM; Fernandez C; Amrán D; Esteban D; de Blas E; Palacios MA; Aller P
J Cell Physiol; 2006 Dec; 209(3):1006-15. PubMed ID: 16972261
[TBL] [Abstract][Full Text] [Related]
6. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK).
Sánchez Y; Amrán D; Fernández C; de Blas E; Aller P
Int J Cancer; 2008 Sep; 123(5):1205-14. PubMed ID: 18546268
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
[TBL] [Abstract][Full Text] [Related]
8. Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases.
Sánchez Y; Calle C; de Blas E; Aller P
Chem Biol Interact; 2009 Nov; 182(1):37-44. PubMed ID: 19720055
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by diethyldithiocarbamate or buthionine sulfoximine.
Han YH; Kim SZ; Kim SH; Park WH
Int J Oncol; 2008 Jul; 33(1):205-13. PubMed ID: 18575767
[TBL] [Abstract][Full Text] [Related]
10. 2-Deoxy-D-glucose cooperates with arsenic trioxide to induce apoptosis in leukemia cells: involvement of IGF-1R-regulated Akt/mTOR, MEK/ERK and LKB-1/AMPK signaling pathways.
Estañ MC; Calviño E; de Blas E; Boyano-Adánez Mdel C; Mena ML; Gómez-Gómez M; Rial E; Aller P
Biochem Pharmacol; 2012 Dec; 84(12):1604-16. PubMed ID: 23041229
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH.
Han YH; Kim SZ; Kim SH; Park WH
Cancer Lett; 2008 Oct; 270(1):40-55. PubMed ID: 18539383
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
Hu XM; Hirano T; Oka K
Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841
[TBL] [Abstract][Full Text] [Related]
13. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
[TBL] [Abstract][Full Text] [Related]
14. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
Lösler S; Schlief S; Kneifel C; Thiel E; Schrezenmeier H; Rojewski MT
Ann Hematol; 2009 Nov; 88(11):1047-58. PubMed ID: 19301004
[TBL] [Abstract][Full Text] [Related]
15. Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid.
Li JJ; Tang Q; Li Y; Hu BR; Ming ZY; Fu Q; Qian JQ; Xiang JZ
Acta Pharmacol Sin; 2006 Aug; 27(8):1078-84. PubMed ID: 16867262
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia.
Lam HK; Li K; Chik KW; Yang M; Liu VC; Li CK; Fok TF; Ng PC; Shing MM; Chuen CK; Yuen PM
Int J Oncol; 2005 Aug; 27(2):537-45. PubMed ID: 16010437
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in arsenic trioxide-treated Calu-6 lung cells is correlated with the depletion of GSH levels rather than the changes of ROS levels.
Han YH; Kim SH; Kim SZ; Park WH
J Cell Biochem; 2008 Jun; 104(3):862-78. PubMed ID: 18393359
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of p38-MAPK potentiates cisplatin-induced apoptosis via GSH depletion and increases intracellular drug accumulation in growth-arrested kidney tubular epithelial cells.
Rodríguez-García ME; Quiroga AG; Castro J; Ortiz A; Aller P; Mata F
Toxicol Sci; 2009 Oct; 111(2):413-23. PubMed ID: 19578154
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of esculetin on arsenic trioxide-provoked apoptosis in human leukemia U937 cells.
Lin TH; Lu FJ; Yin YF; Tseng TH
Chem Biol Interact; 2009 Jun; 180(1):61-8. PubMed ID: 19428345
[TBL] [Abstract][Full Text] [Related]
20. Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines.
Kajiguchi T; Yamamoto K; Iida S; Ueda R; Emi N; Naoe T
Cancer Sci; 2006 Jun; 97(6):540-5. PubMed ID: 16734734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
